- Advertisement -
- Advertisement -

Related

Rhenmans segertåg fortsätter

Industry Report

- Advertisement -

Stockholm (HedgeNordic.com) – Rhenman & Partners hedgefond, Rhenman Healthcare Equity L/S, har återigen visat framfötterna. Efter ett osedvanligt starkt fjolår där fonden steg med dryga 55%, har 2014 visat på fortsatta framgångar. Under augusti månad steg fonden 7,45% vilket tar avkastningen för helåret till 20,27%. Fonden har två år i rad utnämnts till bästa aktiehedgefond vid Nordic Hedge Awards.

I sitt månadsbrev skriver förvaltaren att klimatet inom biotech-sektorn gynnades kraftigt av att läkemedelbolaget Roche lade ett bud på Intermune under månaden. Fondens innehav i Intermune var dock försumbart och istället gynnades fondens utveckling av innehav i Salix (uppköpssekulationer samt förhoppningar utökade godkännanden för läkemedlen Xifaxan och Relistor), Gilead (fortsatt extremt starka försäljningssiffror för hepatit C läkemedlet Sovaldi och förhoppningar om ökad acceptans för preparatet utanför USA) samt Biomarin (som anses vara en uppköpskandidat som inte hängt med utvecklingen för biotech bolag). Bland negativa resultatbidrag märktes innehav som Meda (svaga resultat), Thoratec (svaga resultat) samt Revance (oro för krav på ökad dokumentation vad avser deras botox liknande produkter).

Förvaltaren har en fortsatt positiv syn på fonden för helåret trots fortsatt geopolitisk oro.

Bild: (c) ollyy—shutterstock.com 

 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Kamran Ghalitschi
Kamran Ghalitschi
Kamran has been working in the financial industry since 1994 and has specialized on client relations and marketing. Having worked with retail clients in asset management and brokerage the first ten years of his career for major European banks, he joined a CTA / Managed Futures fund with 1,5 Billion USD under management where he was responsible for sales, client relations and operations in the BeNeLux and Nordic countries. Kamran joined a multi-family office managing their own fund of hedgefunds with 400 million USD AuM in 2009. Kamran has worked and lived in Vienna, Frankfurt, Amsterdam and Stockholm. Born in 1974, Kamran today again lives in Vienna, Austria.

Latest Articles

Aegon AM Launches Capital Call Finance Fund

Aegon Asset Management has launched the Aegon Capital Call Finance Fund, providing institutional investors with access to the capital call finance market – a...

Evli’s Co-Investment Strategy: Opening the Door to Direct Private Equity Deals

Co-investing alongside private equity funds has become increasingly important for institutional investors seeking greater control, reduced fees, and selective deal exposure. Once reserved for...

From Loans to Layers: Navigating the CLO Capital Stack

Collateralized Loan Obligations (CLOs) play an important role in credit markets by bridging the capital needs of corporate borrowers with the return objectives of...

The Changing Role of Private Credit in a New Interest Rate Environment

During the era of near-zero or negative interest rates, traditional fixed income delivered minimal returns, prompting investors to turn to private credit for higher...

Infrastructure: Building Blocks for a Sustainable Future

Infrastructure across many parts of the world is either decades old or, in some regions, barely existent. Against this backdrop, the need for infrastructure...

Investing in Nordic Infrastructure Through Partnership with the Public Sector

Infrastructure investment is often viewed as a public sector responsibility, heavily influenced by political priorities. However, the growing need for new infrastructure projects –...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -
HedgeNordic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.